nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—DRD4—conduct disorder	0.42	0.485	CbGaD
Mirtazapine—SLC6A4—conduct disorder	0.252	0.291	CbGaD
Mirtazapine—HTR2A—conduct disorder	0.194	0.224	CbGaD
Mirtazapine—SLC6A2—autonomic nervous system—conduct disorder	0.00467	0.194	CbGeAlD
Mirtazapine—HTR7—autonomic nervous system—conduct disorder	0.0045	0.187	CbGeAlD
Mirtazapine—HTR2A—autonomic nervous system—conduct disorder	0.00281	0.117	CbGeAlD
Mirtazapine—HRH3—brain—conduct disorder	0.0014	0.0584	CbGeAlD
Mirtazapine—DRD4—brain—conduct disorder	0.00138	0.0576	CbGeAlD
Mirtazapine—Epinastine—HTR2A—conduct disorder	0.00108	0.429	CrCbGaD
Mirtazapine—DRD3—brain—conduct disorder	0.000973	0.0405	CbGeAlD
Mirtazapine—OPRK1—brain—conduct disorder	0.000867	0.0361	CbGeAlD
Mirtazapine—Mianserin—SLC6A4—conduct disorder	0.000811	0.323	CrCbGaD
Mirtazapine—HTR3A—brain—conduct disorder	0.000673	0.028	CbGeAlD
Mirtazapine—Mianserin—HTR2A—conduct disorder	0.000623	0.248	CrCbGaD
Mirtazapine—SLC6A3—brain—conduct disorder	0.00056	0.0233	CbGeAlD
Mirtazapine—HTR2C—brain—conduct disorder	0.000541	0.0225	CbGeAlD
Mirtazapine—ADRB1—brain—conduct disorder	0.000531	0.0221	CbGeAlD
Mirtazapine—SLC6A4—brain—conduct disorder	0.000513	0.0213	CbGeAlD
Mirtazapine—HTR2B—brain—conduct disorder	0.000509	0.0211	CbGeAlD
Mirtazapine—HTR1A—brain—conduct disorder	0.000456	0.0189	CbGeAlD
Mirtazapine—SLC6A2—brain—conduct disorder	0.000452	0.0188	CbGeAlD
Mirtazapine—HTR7—brain—conduct disorder	0.000435	0.0181	CbGeAlD
Mirtazapine—ADRA1A—brain—conduct disorder	0.00042	0.0175	CbGeAlD
Mirtazapine—DRD2—brain—conduct disorder	0.000412	0.0171	CbGeAlD
Mirtazapine—ADRA2C—brain—conduct disorder	0.0004	0.0166	CbGeAlD
Mirtazapine—CYP2C8—brain—conduct disorder	0.000371	0.0154	CbGeAlD
Mirtazapine—HRH1—brain—conduct disorder	0.000325	0.0135	CbGeAlD
Mirtazapine—ADRA2A—brain—conduct disorder	0.000319	0.0133	CbGeAlD
Mirtazapine—HTR2A—brain—conduct disorder	0.000272	0.0113	CbGeAlD
Mirtazapine—CYP2D6—brain—conduct disorder	0.000247	0.0103	CbGeAlD
Mirtazapine—HTR1A—GPCR downstream signaling—CGA—conduct disorder	8.67e-05	0.000802	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR downstream signaling—CGA—conduct disorder	8.62e-05	0.000798	CbGpPWpGaD
Mirtazapine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.59e-05	0.000795	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR ligand binding—DRD4—conduct disorder	8.59e-05	0.000795	CbGpPWpGaD
Mirtazapine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	8.57e-05	0.000793	CbGpPWpGaD
Mirtazapine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.54e-05	0.000791	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR ligand binding—DRD4—conduct disorder	8.54e-05	0.000791	CbGpPWpGaD
Mirtazapine—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.44e-05	0.000782	CbGpPWpGaD
Mirtazapine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	8.41e-05	0.000778	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR downstream signaling—CGA—conduct disorder	8.39e-05	0.000776	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.31e-05	0.000769	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR ligand binding—DRD4—conduct disorder	8.31e-05	0.000769	CbGpPWpGaD
Mirtazapine—HRH3—GPCR downstream signaling—HTR2A—conduct disorder	8.26e-05	0.000765	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—CGA—conduct disorder	8.23e-05	0.000762	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—CGA—conduct disorder	8.05e-05	0.000745	CbGpPWpGaD
Mirtazapine—SLC6A4—Circadian rythm related genes—EP300—conduct disorder	7.97e-05	0.000738	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—CGA—conduct disorder	7.87e-05	0.000728	CbGpPWpGaD
Mirtazapine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	7.84e-05	0.000726	CbGpPWpGaD
Mirtazapine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	7.84e-05	0.000726	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—CGA—conduct disorder	7.83e-05	0.000725	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism of lipids and lipoproteins—CGA—conduct disorder	7.79e-05	0.000721	CbGpPWpGaD
Mirtazapine—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.69e-05	0.000712	CbGpPWpGaD
Mirtazapine—OPRK1—GPCR ligand binding—HTR2A—conduct disorder	7.68e-05	0.000711	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—CGA—conduct disorder	7.62e-05	0.000705	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—CGA—conduct disorder	7.61e-05	0.000704	CbGpPWpGaD
Mirtazapine—HTR7—GPCR ligand binding—HTR2A—conduct disorder	7.56e-05	0.0007	CbGpPWpGaD
Mirtazapine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	7.54e-05	0.000698	CbGpPWpGaD
Mirtazapine—DRD2—GPCR ligand binding—DRD4—conduct disorder	7.54e-05	0.000698	CbGpPWpGaD
Mirtazapine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.53e-05	0.000697	CbGpPWpGaD
Mirtazapine—CYP2D6—Biological oxidations—COMT—conduct disorder	7.52e-05	0.000696	CbGpPWpGaD
Mirtazapine—HRH3—Signaling by GPCR—HTR2A—conduct disorder	7.5e-05	0.000695	CbGpPWpGaD
Mirtazapine—HTR7—Circadian rythm related genes—EP300—conduct disorder	7.5e-05	0.000694	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—CGA—conduct disorder	7.49e-05	0.000693	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—CGA—conduct disorder	7.47e-05	0.000692	CbGpPWpGaD
Mirtazapine—CYP2D6—Biological oxidations—MAOA—conduct disorder	7.46e-05	0.000691	CbGpPWpGaD
Mirtazapine—CYP2C9—Biological oxidations—COMT—conduct disorder	7.45e-05	0.00069	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR ligand binding—DRD4—conduct disorder	7.42e-05	0.000687	CbGpPWpGaD
Mirtazapine—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	7.41e-05	0.000686	CbGpPWpGaD
Mirtazapine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	7.4e-05	0.000685	CbGpPWpGaD
Mirtazapine—HRH1—GPCR ligand binding—DRD4—conduct disorder	7.4e-05	0.000685	CbGpPWpGaD
Mirtazapine—CYP2C9—Biological oxidations—MAOA—conduct disorder	7.4e-05	0.000685	CbGpPWpGaD
Mirtazapine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.36e-05	0.000681	CbGpPWpGaD
Mirtazapine—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	7.35e-05	0.00068	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	7.33e-05	0.000679	CbGpPWpGaD
Mirtazapine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.32e-05	0.000678	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	7.26e-05	0.000672	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	7.26e-05	0.000672	CbGpPWpGaD
Mirtazapine—DRD4—GPCR ligand binding—HTR2A—conduct disorder	7.24e-05	0.00067	CbGpPWpGaD
Mirtazapine—DRD4—Circadian rythm related genes—EP300—conduct disorder	7.18e-05	0.000664	CbGpPWpGaD
Mirtazapine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.12e-05	0.000659	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—CGA—conduct disorder	6.91e-05	0.00064	CbGpPWpGaD
Mirtazapine—HTR2B—GPCR ligand binding—HTR2A—conduct disorder	6.91e-05	0.00064	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—CGA—conduct disorder	6.81e-05	0.00063	CbGpPWpGaD
Mirtazapine—HTR1A—SIDS Susceptibility Pathways—EP300—conduct disorder	6.8e-05	0.00063	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—CGA—conduct disorder	6.8e-05	0.000629	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—DRD4—conduct disorder	6.79e-05	0.000629	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—CGA—conduct disorder	6.78e-05	0.000628	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	6.75e-05	0.000625	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR ligand binding—DRD4—conduct disorder	6.75e-05	0.000625	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—CGA—conduct disorder	6.66e-05	0.000616	CbGpPWpGaD
Mirtazapine—OPRK1—GPCR downstream signaling—DRD4—conduct disorder	6.65e-05	0.000616	CbGpPWpGaD
Mirtazapine—HTR7—GPCR downstream signaling—DRD4—conduct disorder	6.55e-05	0.000606	CbGpPWpGaD
Mirtazapine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	6.46e-05	0.000598	CbGpPWpGaD
Mirtazapine—DRD3—GPCR ligand binding—HTR2A—conduct disorder	6.43e-05	0.000595	CbGpPWpGaD
Mirtazapine—DRD3—Circadian rythm related genes—EP300—conduct disorder	6.37e-05	0.00059	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—CGA—conduct disorder	6.37e-05	0.00059	CbGpPWpGaD
Mirtazapine—CYP1A2—Biological oxidations—COMT—conduct disorder	6.37e-05	0.000589	CbGpPWpGaD
Mirtazapine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	6.34e-05	0.000587	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	6.34e-05	0.000587	CbGpPWpGaD
Mirtazapine—CYP1A2—Biological oxidations—MAOA—conduct disorder	6.32e-05	0.000585	CbGpPWpGaD
Mirtazapine—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	6.28e-05	0.000581	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—CGA—conduct disorder	6.27e-05	0.000581	CbGpPWpGaD
Mirtazapine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	6.22e-05	0.000576	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—CGA—conduct disorder	6.19e-05	0.000573	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—DRD4—conduct disorder	6.04e-05	0.000559	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—CGA—conduct disorder	6.01e-05	0.000556	CbGpPWpGaD
Mirtazapine—HTR2B—GPCR downstream signaling—DRD4—conduct disorder	5.98e-05	0.000554	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—DRD4—conduct disorder	5.95e-05	0.000551	CbGpPWpGaD
Mirtazapine—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	5.88e-05	0.000544	CbGpPWpGaD
Mirtazapine—ADRB1—GPCR ligand binding—HTR2A—conduct disorder	5.86e-05	0.000542	CbGpPWpGaD
Mirtazapine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	5.78e-05	0.000535	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—CGA—conduct disorder	5.73e-05	0.000531	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR ligand binding—HTR2A—conduct disorder	5.73e-05	0.00053	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR ligand binding—HTR2A—conduct disorder	5.6e-05	0.000519	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	5.57e-05	0.000516	CbGpPWpGaD
Mirtazapine—DRD3—GPCR downstream signaling—DRD4—conduct disorder	5.57e-05	0.000515	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—DRD4—conduct disorder	5.43e-05	0.000503	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR ligand binding—HTR2A—conduct disorder	5.42e-05	0.000502	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	5.42e-05	0.000501	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—CGA—conduct disorder	5.38e-05	0.000498	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—CGA—conduct disorder	5.33e-05	0.000494	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—WASF1—conduct disorder	5.11e-05	0.000473	CbGpPWpGaD
Mirtazapine—ADRB1—GPCR downstream signaling—DRD4—conduct disorder	5.07e-05	0.00047	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—DRD4—conduct disorder	5.06e-05	0.000468	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—WASF1—conduct disorder	5.03e-05	0.000465	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR downstream signaling—DRD4—conduct disorder	4.96e-05	0.000459	CbGpPWpGaD
Mirtazapine—DRD2—GPCR ligand binding—HTR2A—conduct disorder	4.92e-05	0.000455	CbGpPWpGaD
Mirtazapine—CYP3A4—Biological oxidations—COMT—conduct disorder	4.91e-05	0.000455	CbGpPWpGaD
Mirtazapine—CYP3A4—Biological oxidations—MAOA—conduct disorder	4.88e-05	0.000452	CbGpPWpGaD
Mirtazapine—DRD2—Circadian rythm related genes—EP300—conduct disorder	4.88e-05	0.000452	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CGA—conduct disorder	4.86e-05	0.00045	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	4.85e-05	0.000449	CbGpPWpGaD
Mirtazapine—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	4.85e-05	0.000449	CbGpPWpGaD
Mirtazapine—HRH1—GPCR ligand binding—HTR2A—conduct disorder	4.83e-05	0.000447	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	4.83e-05	0.000447	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—WASF1—conduct disorder	4.81e-05	0.000446	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CGA—conduct disorder	4.75e-05	0.00044	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	4.74e-05	0.000439	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR downstream signaling—DRD4—conduct disorder	4.7e-05	0.000435	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CGA—conduct disorder	4.65e-05	0.00043	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CGA—conduct disorder	4.63e-05	0.000428	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—DRD4—conduct disorder	4.61e-05	0.000426	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—WASF1—conduct disorder	4.59e-05	0.000425	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—DRD4—conduct disorder	4.51e-05	0.000417	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CGA—conduct disorder	4.5e-05	0.000416	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—HTR2A—conduct disorder	4.43e-05	0.00041	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—DRD4—conduct disorder	4.41e-05	0.000408	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	4.4e-05	0.000408	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—DRD4—conduct disorder	4.38e-05	0.000406	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—CGA—conduct disorder	4.37e-05	0.000404	CbGpPWpGaD
Mirtazapine—OPRK1—GPCR downstream signaling—HTR2A—conduct disorder	4.34e-05	0.000402	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—WASF1—conduct disorder	4.28e-05	0.000396	CbGpPWpGaD
Mirtazapine—HTR7—GPCR downstream signaling—HTR2A—conduct disorder	4.27e-05	0.000396	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—DRD4—conduct disorder	4.26e-05	0.000395	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—DRD4—conduct disorder	4.26e-05	0.000394	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	4.19e-05	0.000388	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—DRD4—conduct disorder	4.18e-05	0.000387	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	4.11e-05	0.00038	CbGpPWpGaD
Mirtazapine—DRD4—GPCR downstream signaling—HTR2A—conduct disorder	4.09e-05	0.000379	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CGA—conduct disorder	4.08e-05	0.000378	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CGA—conduct disorder	4.02e-05	0.000372	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CGA—conduct disorder	4.01e-05	0.000371	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—HTR2A—conduct disorder	3.94e-05	0.000365	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CGA—conduct disorder	3.93e-05	0.000364	CbGpPWpGaD
Mirtazapine—HTR2B—GPCR downstream signaling—HTR2A—conduct disorder	3.9e-05	0.000361	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—WASF1—conduct disorder	3.9e-05	0.000361	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—HTR2A—conduct disorder	3.88e-05	0.000359	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—DRD4—conduct disorder	3.87e-05	0.000358	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	3.81e-05	0.000353	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—WASF1—conduct disorder	3.81e-05	0.000353	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—DRD4—conduct disorder	3.81e-05	0.000352	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—DRD4—conduct disorder	3.8e-05	0.000352	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	3.73e-05	0.000345	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—WASF1—conduct disorder	3.73e-05	0.000345	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—HTR2A—conduct disorder	3.71e-05	0.000344	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—WASF1—conduct disorder	3.71e-05	0.000343	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CGA—conduct disorder	3.65e-05	0.000338	CbGpPWpGaD
Mirtazapine—DRD3—GPCR downstream signaling—HTR2A—conduct disorder	3.63e-05	0.000336	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—WASF1—conduct disorder	3.61e-05	0.000334	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—DRD4—conduct disorder	3.57e-05	0.00033	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—HTR2A—conduct disorder	3.55e-05	0.000328	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—DRD4—conduct disorder	3.51e-05	0.000325	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—CGA—conduct disorder	3.47e-05	0.000321	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	3.46e-05	0.000321	CbGpPWpGaD
Mirtazapine—ADRB1—GPCR downstream signaling—HTR2A—conduct disorder	3.31e-05	0.000306	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—HTR2A—conduct disorder	3.3e-05	0.000305	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—WASF1—conduct disorder	3.27e-05	0.000303	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR downstream signaling—HTR2A—conduct disorder	3.24e-05	0.0003	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—WASF1—conduct disorder	3.22e-05	0.000298	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—WASF1—conduct disorder	3.21e-05	0.000297	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—DRD4—conduct disorder	3.21e-05	0.000297	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	3.17e-05	0.000293	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—WASF1—conduct disorder	3.15e-05	0.000292	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	3.15e-05	0.000292	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR downstream signaling—HTR2A—conduct disorder	3.06e-05	0.000284	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—HTR2A—conduct disorder	3.01e-05	0.000278	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—DRD4—conduct disorder	2.99e-05	0.000277	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—HTR2A—conduct disorder	2.94e-05	0.000272	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—WASF1—conduct disorder	2.93e-05	0.000271	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	2.88e-05	0.000266	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	2.86e-05	0.000265	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—CGA—conduct disorder	2.85e-05	0.000264	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—CGA—conduct disorder	2.82e-05	0.000261	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—HTR2A—conduct disorder	2.78e-05	0.000258	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	2.78e-05	0.000257	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—HTR2A—conduct disorder	2.73e-05	0.000253	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—DRD4—conduct disorder	2.72e-05	0.000252	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	2.68e-05	0.000248	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—DRD4—conduct disorder	2.66e-05	0.000246	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—DRD4—conduct disorder	2.6e-05	0.000241	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—DRD4—conduct disorder	2.59e-05	0.00024	CbGpPWpGaD
Mirtazapine—ADRA2C—Hemostasis—EP300—conduct disorder	2.57e-05	0.000238	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—HTR2A—conduct disorder	2.52e-05	0.000234	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—DRD4—conduct disorder	2.52e-05	0.000233	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	2.49e-05	0.00023	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—HTR2A—conduct disorder	2.48e-05	0.000229	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	2.43e-05	0.000225	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—COMT—conduct disorder	2.43e-05	0.000225	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—CGA—conduct disorder	2.41e-05	0.000223	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—MAOA—conduct disorder	2.41e-05	0.000223	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—EP300—conduct disorder	2.35e-05	0.000217	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—HTR2A—conduct disorder	2.33e-05	0.000216	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—HTR2A—conduct disorder	2.29e-05	0.000212	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—DRD4—conduct disorder	2.29e-05	0.000212	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	2.26e-05	0.000209	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—DRD4—conduct disorder	2.25e-05	0.000208	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—DRD4—conduct disorder	2.24e-05	0.000208	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—DRD4—conduct disorder	2.2e-05	0.000204	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—HTR2A—conduct disorder	2.19e-05	0.000203	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—HTR2A—conduct disorder	2.09e-05	0.000194	CbGpPWpGaD
Mirtazapine—ADRA2A—Hemostasis—EP300—conduct disorder	2.09e-05	0.000193	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—DRD4—conduct disorder	2.05e-05	0.000189	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—COMT—conduct disorder	1.97e-05	0.000183	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—MAOA—conduct disorder	1.96e-05	0.000181	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—HTR2A—conduct disorder	1.95e-05	0.00018	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CGA—conduct disorder	1.86e-05	0.000172	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—HTR2A—conduct disorder	1.78e-05	0.000164	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—HTR2A—conduct disorder	1.74e-05	0.000161	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—HTR2A—conduct disorder	1.7e-05	0.000157	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—HTR2A—conduct disorder	1.69e-05	0.000156	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—HTR2A—conduct disorder	1.64e-05	0.000152	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—COMT—conduct disorder	1.57e-05	0.000145	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—MAOA—conduct disorder	1.55e-05	0.000144	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.51e-05	0.00014	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—HTR2A—conduct disorder	1.49e-05	0.000138	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—HTR2A—conduct disorder	1.46e-05	0.000136	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	1.44e-05	0.000133	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	1.34e-05	0.000124	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—COMT—conduct disorder	1.29e-05	0.000119	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—MAOA—conduct disorder	1.28e-05	0.000118	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—COMT—conduct disorder	1.27e-05	0.000118	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—MAOA—conduct disorder	1.27e-05	0.000117	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—EP300—conduct disorder	1.23e-05	0.000114	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.23e-05	0.000114	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—EP300—conduct disorder	1.21e-05	0.000112	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—EP300—conduct disorder	1.16e-05	0.000108	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—EP300—conduct disorder	1.11e-05	0.000103	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—COMT—conduct disorder	1.09e-05	0.000101	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—MAOA—conduct disorder	1.08e-05	0.0001	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.05e-05	9.71e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—EP300—conduct disorder	1.04e-05	9.64e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—EP300—conduct disorder	1.03e-05	9.56e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—EP300—conduct disorder	9.41e-06	8.71e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—EP300—conduct disorder	9.2e-06	8.52e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—EP300—conduct disorder	9e-06	8.33e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—EP300—conduct disorder	8.95e-06	8.29e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—EP300—conduct disorder	8.71e-06	8.06e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—EP300—conduct disorder	8.46e-06	7.83e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—COMT—conduct disorder	8.4e-06	7.78e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—MAOA—conduct disorder	8.34e-06	7.72e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—EP300—conduct disorder	7.9e-06	7.31e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—EP300—conduct disorder	7.77e-06	7.2e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—EP300—conduct disorder	7.76e-06	7.18e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—EP300—conduct disorder	7.61e-06	7.05e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—EP300—conduct disorder	7.07e-06	6.55e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—EP300—conduct disorder	6.71e-06	6.21e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—EP300—conduct disorder	5.51e-06	5.1e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—EP300—conduct disorder	5.46e-06	5.06e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—EP300—conduct disorder	4.67e-06	4.32e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—EP300—conduct disorder	3.6e-06	3.34e-05	CbGpPWpGaD
